YY1 and cancer: YY1 over-expression has also been previously reported ex vivo in different cancer types, including those of the breast [62], bladder [63], prostate [64], gastrointestinal [65], ovaries [66], esophagus [67], nervous system [68], pancreas [69], and skin [70].